Authorities in Guangdong, China, granted medical device certificates for two of Shenzhen New Industries Biomedical Engineering's (SHE:300832) testing kits.
The lambda and kappa light chain assay kits help diagnose autoimmune diseases and conditions in the liver, kidney, and for myeloma treatment, according to a Wednesday filing with the Shenzhen bourse.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments